Small Molecules
Large Scale

Our Partners

Supported by leading industry players, including Merck, AstraZeneca, the Israeli
Biotech Fund (IBF), and Aion Labs.

Biology Meets AI

Integrating biology and machine learning is revolutionizing drug discovery, unlocking new therapeutic possibilities.
The Data Explosion: Exponentially growing biological data is creating unprecedented opportunities for AI-driven insights.

Beyond Traditional Computation: 3D simulations and brute-force screening are being replaced by adaptive, predictive approaches that accelerate discovery.

A New Era in Drug Discovery: AI-powered molecular modeling and dynamic protein structure prediction redefine how we identify and develop treatments.

Our Focus

Small Molecules

The foundation of most modern drugs, offering precision, scalability, and proven therapeutic value.

Undiscovered Protein Structures

Nearly half of all known proteins lack structural data, presenting untapped opportunities for drug discovery.

AI-Driven Discovery

Combining computational biology with machine learning to uncover new interactions and accelerate drug development.

Why Prophet?

Accuracy: Utilizing the hidden patterns embedded within biological data to model the dynamic nature of proteins for more precise drug identification.

Speed & Scale: AI-driven screening, accelerating discovery by orders of magnitude— allowing to realistically find more needles in an ever-growing haystack, making breakthroughs faster and more efficient. 

Interpretability: Delivering transparent, scientifically interpretable insights – enhancing trust and confidence in drug discovery outcomes.